Information title
Published on Thursday 04 September 2008 - 09:49
Summary :
Mike Huckman submits: In late July at a big scientific conference in Chicago, I reported on new, positive data on Medivation's (MDVN) experimental Alzheimer's drug Dimebon (dim-uh-bahn). In...
Read more
Information source
SeekingAlpha.com: Home Page
http://seekingalpha.com
Website description
Long and short investing ideas, stock quotes, market news, analysis, blogs, and free conference call transcripts.
Articles published on this website : 0 / 7 days - 1 / 30 days
Will TorreyPines Sale of Its Alzheimer Genetics Research
Glaxo and AFFiRiS Sign Alzheimer’s Disease Vaccine Deal
Wyeth Cuts Back Too: Are New Opportunities Being
Neuroptix Raises $18.5 Million in Successful B Round
Archer Pharmaceuticals: New Company to Target Alzheimer’s Disease
Other articles published on other websites on the same day
Epix regains commercialization rights to Vasovist
http://www.fiercebiotech.com/ Time Domain Delivers Ultra Wideband (UWB) Real-Time Precision Location of Alzheimer's Patients, Staff and Equipment at Nesconset Center for Nursing...
http://www.prnewswire.com/ Alzheimer's Society Comment On New Research Demonstrating That Exercise Improves Cognition In People With Mild Cognitive Impairment, Published In JAMA
http://www.medicalnewstoday.com/ Rhode Island Hospital study finds link between obesity, type 2 diabetes and neurodegeneration
http://www.eurekalert.org/ Pfizer Shells Out Millions To Help Bay Area Biotech Company
http://www.nbc11.com/ APPRECIATION: Gould never just a coach
http://www.dailynewstribune.com/ Alzheimer's support group meeting Sept. 18
http://nbs.gmnews.com/
